A legitimate pharmacy fulfills the prescription if appropriate
FDA labeling for EGRIFTA WR states that tesamorelin is indicated for reducing excess abdominal fat in HIV-infected adults with lipodystrophy, while also noting that it is not indicated for weight-loss management and that long-term cardiovascular safety has not been established. For a research comparison article, Tesamorelin gives useful context: it shows that the GHRH analog category is not limited to CJC-1295 and Sermorelin
This mechanism explains why PT-141 works differently than anything else
For more such Replying to @thebigbulldeals#Shaily Engineering Plastics -Strong Growth Play in High-Margin Healthcare & Plastics
Therefore, it is not a copy of Mounjaro or Zepbound
Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR